Skip to main content
Commentary
Life after COVID-19: R WE going to help?
- Sreeram V Ramagopalan and
- Radek Wasiak
pp525–526
Published Online:11 May 2020
Systematic Review
Surfactant therapy for meconium aspiration syndrome in neonates: a systematic overview of systematic reviews and recent clinical trials
- Mohammed Ahmed Abdelaal,
- Dina Abushanab, and
- Daoud Al-Badriyeh
pp527–536
Published Online:12 May 2020
Research Article
Real-world direct healthcare costs of treating recurrent high-grade serous ovarian cancer with cytotoxic chemotherapy
- Lucy Gilbert,
- Agnihotram V Ramanakumar,
- Maria Carolina Festa,
- Kris Jardon,
- Xing Zeng,
- Claudia Martins,
- Layla Shbat,
- Marwa Abo Alsoud,
- Manuel Borod,
- Michael Wolfson,
- Ioanna Papaioannou,
- Olga Basso, and
- John Sampalis
pp537–551
Published Online:30 March 2020
- This article corrects the following:
Corrigendum
- Volume 14Issue 3Journal of Comparative Effectiveness Research
- 7 January 2025
Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost–effectiveness analysis
- Hongfu Cai,
- Longfeng Zhang,
- Na Li,
- Bin Zheng, and
- Maobai Liu
pp553–562
Published Online:18 May 2020
Can a biomarker triage test reduce colonoscopy burden in fecal immunochemical test screening?
- Marjolein JE Greuter,
- Beatriz Carvalho,
- Meike de Wit,
- Evelien Dekker,
- Manon CW Spaander,
- Gerrit A Meijer,
- Manon van Engeland, and
- Veerle MH Coupé
pp563–571
Published Online:28 May 2020
US database study: burden and healthcare resource utilization in adults with systemic endemic mycoses and aspergillosis
- Anna Forsythe,
- Gareth Lewis,
- Robyn Jordan, and
- George R Thompson
pp573–584
Published Online:22 April 2020
Assessing risk of bias judgments for blinding of outcome assessors in Cochrane reviews
- Ognjen Barcot,
- Svjetlana Dosenovic,
- Matija Boric,
- Tina Poklepovic Pericic,
- Marija Cavar,
- Antonia Jelicic Kadic, and
- Livia Puljak
pp585–593
Published Online:27 May 2020
Erratum
Erratum
pp595–597
Published Online:9 April 2020
- Correction(s) for this article
Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease
- Volume 8Issue 15Journal of Comparative Effectiveness Research
- 27 September 2019